ANO4 | Anoctamin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CDS2 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
LBR | Lamin B receptor | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
NIPAL1 | NIPA-like domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
RHCG | Rh family, C glycoprotein | Predicted membrane proteins Transporters
| | | | | Group enriched |
SERINC5 | Serine incorporator 5 | Predicted membrane proteins
| | | | | Expressed in all |
SGPP1 | Sphingosine-1-phosphate phosphatase 1 | Predicted membrane proteins
| | | | | Expressed in all |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A4 | Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC1A5 | Solute carrier family 1 (neutral amino acid transporter), member 5 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC26A6 | Solute carrier family 26 (anion exchanger), member 6 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC34A2 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 2 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC37A4 | Solute carrier family 37 (glucose-6-phosphate transporter), member 4 | Predicted membrane proteins
| | | | | Expressed in all |
SLC44A4 | Solute carrier family 44, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC4A4 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC6A18 | Solute carrier family 6 (neutral amino acid transporter), member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC8A1 | Solute carrier family 8 (sodium/calcium exchanger), member 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC8A2 | Solute carrier family 8 (sodium/calcium exchanger), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SPNS1 | Spinster homolog 1 (Drosophila) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SPPL2A | Signal peptide peptidase like 2A | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
TAP1 | Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TM9SF2 | Transmembrane 9 superfamily member 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
TMC5 | Transmembrane channel-like 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM63B | Transmembrane protein 63B | Predicted membrane proteins Transporters
| | | | | Expressed in all |